Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €39.87 and traded as high as €40.25. Fresenius Medical Care shares last traded at €39.45, with a volume of 1,433,204 shares.
Fresenius Medical Care Price Performance
The company has a debt-to-equity ratio of 87.31, a quick ratio of 0.80 and a current ratio of 1.07. The company has a 50-day simple moving average of €41.65 and a 200-day simple moving average of €39.87. The company has a market cap of $11.64 billion, a price-to-earnings ratio of 17.66, a PEG ratio of 0.42 and a beta of 0.94.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
- Five stocks we like better than Fresenius Medical Care
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
